These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 922247)

  • 41. Characterization of ouabain-induced noradrenaline and acetylcholine release from in situ cardiac autonomic nerve endings.
    Yamazaki T; Akiyama T; Kitagawa H; Komaki F; Mori H; Kawada T; Sunagawa K; Sugimachi M
    Acta Physiol (Oxf); 2007 Dec; 191(4):275-84. PubMed ID: 17995575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modification of potassium-evoked release of noradrenaline by various ions and agents.
    Kirpekar SM; Prat JC; Schiavone MT
    Br J Pharmacol; 1983 Feb; 78(2):277-85. PubMed ID: 6831114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of axonal transport of new amine granules for 3 H-noradrenaline retention capacity of adrenergic nerve terminals.
    Häggendal J; Dahlström A
    Acta Physiol Pol; 1973; 24(1):185-92. PubMed ID: 4351939
    [No Abstract]   [Full Text] [Related]  

  • 44. Reversal of guanethidine blockade of sympathetic nerve terminals by tetraethylammonium and 4-aminopyridine.
    Kirpekar M; Kirpekar SM; Prat JC
    Br J Pharmacol; 1978 Jan; 62(1):75-8. PubMed ID: 620099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of ouabain on noradrenaline output from peripheral adrenergic neurones of isolated guinea-pig vas deferens.
    Nakazato Y; Ohga A; Onoda Y
    J Physiol; 1978 May; 278():45-54. PubMed ID: 671328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic potential of H(3)-receptor agonists in myocardial infarction.
    Mackins CJ; Levi R
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2537-42. PubMed ID: 11060818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of noradrenaline depletion on large dense-cored vesicles in sympathetic nerve terminals.
    Mottram DR
    Neuropharmacology; 1975 Feb; 14(2):91-4. PubMed ID: 1153084
    [No Abstract]   [Full Text] [Related]  

  • 48. Formation of dopamine and noradrenaline in rat vas deferens: comparison with guinea-pig vas deferens.
    Boadle-Biber MC; Roth RH
    Br J Pharmacol; 1975 Sep; 55(1):73-8. PubMed ID: 1182351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Release of noradrenaline by splenic nerve stimulation and its dependence on calcium.
    Kirpekar SM; Misu Y
    J Physiol; 1967 Jan; 188(2):219-34. PubMed ID: 6030514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of drugs on adrenergic nerve terminals.
    von Euler US
    Adv Cytopharmacol; 1971 May; 1():363-7. PubMed ID: 4148190
    [No Abstract]   [Full Text] [Related]  

  • 51. A-23187 evoked transmitter release from rabbit pulmonary artery and its inhibition by reactivation of sodium-pump.
    Török TL; Rácz D; Tóth PT; Azzidani AM; Powis DA; Magyar K
    Gen Pharmacol; 1989; 20(4):421-5. PubMed ID: 2568967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presynaptic alpha2-receptors regulate reverse Na+/Ca2+-exchange and transmitter release in Na+-loaded peripheral sympathetic nerves.
    Török TL; Nagykáldi Z; Sáska Z; Kovács T; Nada SA; Zilliikens S; Magyar K; Sylvester Vizi E
    Neurochem Int; 2004 Oct; 45(5):699-711. PubMed ID: 15234113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyramine-induced endogenous noradrenaline efflux from in situ cardiac sympathetic nerve ending in cats.
    Takauchi Y; Yamazaki T; Akiyama T
    Acta Physiol Scand; 2000 Feb; 168(2):287-93. PubMed ID: 10712566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3 H-noradrenaline-accumulating ability of cholinergic nerve terminals in cat sympathetic ganglia.
    Graham JD; Ivens C; Lever JD; Joó F; Mottram DR; Spriggs TL
    Br J Pharmacol; 1971 Nov; 43(3):555-9. PubMed ID: 5157722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals.
    Risso F; Grilli M; Parodi M; Bado M; Raiteri M; Marchi M
    Neuropharmacology; 2004 Jul; 47(1):65-71. PubMed ID: 15165834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of sodium and potassium ions in storage of norepinephrine by sympathetic nerve endings.
    Bogdanski DF; Brodie BB
    Life Sci; 1966 Sep; 5(17):1563-9. PubMed ID: 5970679
    [No Abstract]   [Full Text] [Related]  

  • 57. Involvement of cholinergic nicotine-like receptors as modulators of amine turnover in various types of hypothalamic dopamine and noradrenaline nerve terminal systems and of prolactin, LH, FSH and TSH secretion in the castrated male rat.
    Andersson K; Fuxe K; Eneroth P; Agnati LF
    Acta Physiol Scand; 1982 Sep; 116(1):41-50. PubMed ID: 6818838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depolarization promotes caffeine induced [3H]-noradrenaline release in calcium-free solution from peripheral sympathetic nerves.
    Tóth PT; Török TL; Magyar K
    Cell Calcium; 1990 Oct; 11(9):557-63. PubMed ID: 2126748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible role of sodium and calcium ions in retention and physiological release of norepinephrine by adrenergic nerve endings.
    Blaszkowski TP; Bogdanski DF
    Biochem Pharmacol; 1971 Dec; 20(12):3281-94. PubMed ID: 5132878
    [No Abstract]   [Full Text] [Related]  

  • 60. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):30-41. PubMed ID: 5087403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.